MITTEL SPA (MIT.MI) Stock Fundamental Analysis

BIT:MIT • IT0001447348

1.745 EUR
0 (0%)
Last: Mar 5, 2025, 10:29 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

MIT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 56 industry peers in the Financial Services industry. While MIT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MIT has a valuation in line with the averages, but on the other hand it scores bad on growth. MIT also has an excellent dividend rating. With these ratings, MIT could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • MIT had positive earnings in the past year.
  • In the past year MIT had a positive cash flow from operations.
  • In the past 5 years MIT has always been profitable.
  • MIT had a positive operating cash flow in each of the past 5 years.
MIT.MI Yearly Net Income VS EBIT VS OCF VS FCFMIT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

  • With an excellent Return On Assets value of 12.51%, MIT belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
  • With a decent Return On Equity value of 19.94%, MIT is doing good in the industry, outperforming 72.00% of the companies in the same industry.
  • MIT has a Return On Invested Capital of 19.42%. This is amongst the best in the industry. MIT outperforms 90.00% of its industry peers.
  • MIT had an Average Return On Invested Capital over the past 3 years of 14.88%. This is significantly above the industry average of 8.48%.
  • The 3 year average ROIC (14.88%) for MIT is below the current ROIC(19.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROIC 19.42%
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
MIT.MI Yearly ROA, ROE, ROICMIT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

  • MIT's Profit Margin of 33.36% is fine compared to the rest of the industry. MIT outperforms 72.00% of its industry peers.
  • MIT's Profit Margin has improved in the last couple of years.
  • The Operating Margin of MIT (49.36%) is better than 86.00% of its industry peers.
  • In the last couple of years the Operating Margin of MIT has grown nicely.
  • With an excellent Gross Margin value of 100.33%, MIT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MIT has grown nicely.
Industry RankSector Rank
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
MIT.MI Yearly Profit, Operating, Gross MarginsMIT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • MIT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for MIT remains at a similar level compared to 1 year ago.
  • MIT has a better debt/assets ratio than last year.
MIT.MI Yearly Shares OutstandingMIT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MIT.MI Yearly Total Debt VS Total AssetsMIT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

  • MIT has an Altman-Z score of 2.36. This is not the best score and indicates that MIT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of MIT (2.36) is comparable to the rest of the industry.
  • MIT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.18, MIT is doing good in the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACC3.26
WACC5.96%
MIT.MI Yearly LT Debt VS Equity VS FCFMIT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.89 indicates that MIT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.89, MIT belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
  • A Quick Ratio of 1.90 indicates that MIT should not have too much problems paying its short term obligations.
  • MIT has a better Quick ratio (1.90) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.9
MIT.MI Yearly Current Assets VS Current LiabilitesMIT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has been growing by 106.03% on average over the past years. This is a very strong growth
  • MIT shows a decrease in Revenue. In the last year, the revenue decreased by -2.49%.
  • The Revenue has been growing slightly by 5.85% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIT.MI Yearly Revenue VS EstimatesMIT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
MIT.MI Yearly EPS VS EstimatesMIT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.81, the valuation of MIT can be described as very cheap.
  • Based on the Price/Earnings ratio, MIT is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of MIT to the average of the S&P500 Index (27.10), we can say MIT is valued rather cheaply.
Industry RankSector Rank
PE 2.81
Fwd PE N/A
MIT.MI Price Earnings VS Forward Price EarningsMIT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • MIT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MIT is cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.23
MIT.MI Per share dataMIT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • The excellent profitability rating of MIT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • MIT has a Yearly Dividend Yield of 7.04%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.21, MIT pays a better dividend. On top of this MIT pays more dividend than 90.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, MIT pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.04%

5.2 History

  • The dividend of MIT is nicely growing with an annual growth rate of 31.64%!
Dividend Growth(5Y)31.64%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • MIT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
MIT.MI Yearly Income VS Free CF VS DividendMIT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

MITTEL SPA

BIT:MIT (3/5/2025, 10:29:18 AM)

1.745

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A
Earnings (Next)04-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners79.04%
Ins Owner ChangeN/A
Market Cap141.96M
Revenue(TTM)151.39M
Net Income(TTM)50.50M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.04%
Yearly Dividend0.01
Dividend Growth(5Y)31.64%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.81
Fwd PE N/A
P/S 0.94
P/FCF N/A
P/OCF 16.71
P/B 0.56
P/tB 0.77
EV/EBITDA 1.23
EPS(TTM)0.62
EY35.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.1
OCFY5.98%
SpS1.86
BVpS3.11
TBVpS2.26
PEG (NY)N/A
PEG (5Y)0.03
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROCE 22.74%
ROIC 19.42%
ROICexc 25.34%
ROICexgc 34.77%
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
FCFM N/A
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
ROICexc(3y)18.47%
ROICexc(5y)13.76%
ROICexgc(3y)25.01%
ROICexgc(5y)18.45%
ROCE(3y)17.14%
ROCE(5y)12.72%
ROICexgc growth 3Y36.07%
ROICexgc growth 5Y64.28%
ROICexc growth 3Y32.02%
ROICexc growth 5Y65.98%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 198.12%
Cap/Sales 13.09%
Interest Coverage 28.12
Cash Conversion 10.03%
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.9
Altman-Z 2.36
F-Score5
WACC5.96%
ROIC/WACC3.26
Cap/Depr(3y)179.03%
Cap/Depr(5y)134.19%
Cap/Sales(3y)13.45%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.29%
EBIT growth 3Y4.78%
EBIT growth 5Y67.8%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-514.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.3%
OCF growth 3Y-29.55%
OCF growth 5Y-15.3%

MITTEL SPA / MIT.MI FAQ

What is the ChartMill fundamental rating of MITTEL SPA (MIT.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MIT.MI.


What is the valuation status for MIT stock?

ChartMill assigns a valuation rating of 4 / 10 to MITTEL SPA (MIT.MI). This can be considered as Fairly Valued.


What is the profitability of MIT stock?

MITTEL SPA (MIT.MI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of MITTEL SPA (MIT.MI) stock?

The Price/Earnings (PE) ratio for MITTEL SPA (MIT.MI) is 2.81 and the Price/Book (PB) ratio is 0.56.